Evolution of concomitant moderate and moderate to severe functional mitral regurgitation following aortic valve surgery for severe aortic stenosis

  • Petar Dabić Dedinje Cardiovascular Institute, Belgrade
  • Saša Borović Dedinje Cardiovascular Institute
  • Predrag Milojević Dedinje Cardiovascular Institute Belgrade
  • Jelena V Kostić Clinical Center of Serbia
  • Zoran Trifunović Military Medical Academy
  • Rade Babić Dedinje Cardiovascular Institute
Keywords: mitral valve insufficiency;, aortic valve stenosis;, cardio-vascular surgical procedures;, postoperative period

Abstract


Background/Aim. Functional mitral regurgitation (FMR) is a common entity in patients with aortic stenosis (AS) undergoing aortic valve replacement (AVR). The aim of this study was to examine evolution of moderate and moderate to severe FMR after an isolated AVR, to identify prognostic indicators for persistent MR postoperatively, and to offer the recommendation regarding surgical intervention for moderate and moderate to severe FMR at the time of AVR for AS. Methods. We retrospectively reviewed 39 conse­cu­tive patients with moderate and moderate to severe FMR at the time of isolated AVR from January 2007 to December 2013. We collected preoperative and postoperative echo­cardiographic data to determine the evolution of FMR after AVR. Patients were divided into the persistent (n = 14) and improved FMR group (n = 25). Secondary division was into the prosthesis-patient mismatch (PPM, n = 7) and non prosthesis-patient mismatch group (non PPM, n = 32 patients). Late follow-up echocardiography was completed in 100% (39/39) of patients. Results. FMR improved postoperatively (MR ˂ 2+) in 64% (25/39) of patients, while 36% (14/39) of patients had persistent MR ≥ 2). In comparison to the persistent group, the patient with impro­ved FMR had significant decrease in the left ventricular end-diastolic diameter, left ventricular end-systolic diameter, posterior wall and septum thickness postoperatively. The same indicators of reverse remodeling were found in the non PPM group in comparison to the PPM group. The incidence of postoperative FMR improvement was higher in the non PPM group (65.6%, p = 0.001) in comparison to thePPM group (42.9%, p = 0.125). The mean follow-up duration was 39.5 ± 23.5 months. Conclusion. In accor­dance with previous studies, this study also showed impro­vement in FMR following AVR surgery. Improvement in MR degree was associated with echocardiographic para­meters of reverse left ventricular remodeling. Conservative approach is advisable in patients with moderate and mo­derate to severe FMR, believing that repair or replacement is unnecessary at the time of AVR for severe AS. PPM could prevent downgrading of FMR, stressing out the importance of choosing the prosthesis of adequate size.

References

Unger P, Dedobbeleer C, Van Camp G, Plein D, Cosyns B, Lancel-lotti P. Mitral regurgitation in patients with aortic stenosis un-dergoing valve replacement. Heart 2010; 96(1): 9‒14.

Moazami N, Diodato MD, Moon MR, Lawton JS, Pasque MK, Herren RL, et al. Does functional mitral regurgitation improve with isolated aortic valve replacement? J Card Surg 2004; 19(5): 444‒8.

Nishimura RA, , Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the man-agement of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014; 148(1): e1‒e132.

Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardi-ology (ESC)1; European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33(19): 2451‒96.

Gillinov AM, Blackstone EH, Cosgrove DM 3rd, White J, Kerr P, Marullo A, et al. Mitral valve repair with aortic valve replace-ment is superior to double valve replacement. J Thorac Cardi-ovasc Surg 2003; 125(6): 1372–87.

Talwar S, Mathur A, Choudhary SK, Singh R, Kumar AS. Aortic valve replacement with mitral valve repair compared with combined aortic and mitral valve. Ann Thorac Surg 2007; 84(4): 1219–25.

Schubert SA, Yarboro LT, Madala S, Ayunipudi K, Kron IL, Kern JA, et al. Natural history of coexistent mitral regurgitation af-ter aortic valve replacement. J Thorac Cardiovasc Surg 2016; 151(4): 1032‒9, 1042.e1.

Barreiro CJ, Patel ND, Fitton TP, Williams JA, Bonde PN, Chan V, et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly. Impact on survival and functional outcome. Circulation 2005;112(9 Suppl ): I443–7.

Vanden Eynden F, Bouchard D, El-Hamamsy I, Butnaru A, Demers P, Carrier M, et al. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Ann Thorac Surg 2007; 83(4): 1279–84.

Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16(7): 777‒802.

Harling L, Saso S, Jarral OA, Kourliouros A, Kidher E, Athanasiou T. Aortic valve replacement for aortic stenosis in patients with concomitant mitral regurgitation: should the mitral valve be dealt with? Eur J Cardiothorac Surg 2011; 40(5): 1087‒96.

Brasch AV, Khan SS, DeRobertis MA, Kong JH, Chiu J, Siegel RJ. Change in mitral regurgitation severity after aortic valve re-placement for aortic stenosis. Am J Cardiol 2000; 85(10): 1271‒4.

Unger P, Plein D, Van Camp G, Cosyns B, Pasquet A, Henrard V, et al. Effects of valve replacement for aortic stenosis on mitral regurgitation. Am J Cardiol 2008; 102(10): 1378‒82.

Wan CK, Suri RM, Li Z, Orszulak TA, Daly RC, Schaff HV, et al. Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary? J Thorac Cardiovasc Surg 2009; 137(3): 635‒40.e1.

Sitges M, Vidal B, Delgado V, Mont L, Garcia-Alvarez A, Tolo-sana JM, et al. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. Am J Cardiol 2009; 104(3): 383‒8.

Alghamdi AA, Elmistekawy EM, Singh SK, Latter DA. Is con-comitant surgery for moderate functional mitral regurgitation indicated during aortic valve replacement for aortic stenosis? A systematic review and evidence-based recommendations. J Card Surg 2010; 25(2): 182‒7.

Brasch AV, Khan SS, DeRobertis MA, Kong JHK, Chiu J, Siegel RJ. Change in mitral regurgitation severity after aortic valve replacement for aortic stenosis. Am J Cardiol 2000; 85(10): 1271‒4.

Joo H, Chang B, Cho S, Youn Y, Yoo K, Lee S. Fate of functional mitral regurgitation and predictors of persistent mitral regurgi-tation after isolated aortic valve replacement. Ann Thorac Surg 2011; 92(1): 82‒8.

Jeong DS, Park PW, Sung K, Kim WS, Yang JH, Jun TG, et al. Long-term clinical impact of functional mitral regurgitation after aortic valve replacement. Ann Thorac Surg 2011; 92(4): 1339‒45.

Sehovic S, Talic A, Kacila M, Tahirovic E. The influence of aortic valve replacement on functional moderate-to-severe mitral re-gurgitation in patients with aortic valve stenosis. Acta Inform Med 2015; 23(3): 147–50.

Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 2003; 108(8): 983‒8.

Waisbren EC, Stevens LM, Avery EG, Picard MH, Vlahakes GJ, Agnihotri AK. Changes in mitral regurgitation after replace-ment of the stenotic aortic valve. Ann Thorac Surg 2008; 86(1): 56‒62.

Published
2021/05/06
Section
Original Paper